Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GeneDx

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
From GeneDx
Via Business Wire
Tickers WGS
GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program
From GeneDx
Via Business Wire
Tickers WGS
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
From GeneDx
Via Business Wire
Tickers WGS
GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
From GeneDx
Via Business Wire
Tickers WGS
GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors
From GeneDx
Via Business Wire
Tickers WGS
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights
From GeneDx
Via Business Wire
Tickers WGS
GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability
From GeneDx
Via Business Wire
Tickers WGS
Galatea Bio and Fabric Genomics Partner to Deliver Comprehensive Genetic Testing for Common Diseases
From GeneDx
Via Business Wire
Tickers WGS
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Announces Completion of Fabric Genomics Acquisition
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Reports First Quarter 2025 Financial Results and Business Highlights
From GeneDx
Via Business Wire
Tickers WGS
GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale
From GeneDx
Via Business Wire
Tickers WGS
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GeneDx
Via Business Wire
Tickers WGS
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies
From GeneDx
Via Business Wire
Tickers WGS
GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis
From GeneDx
Via Business Wire
Tickers WGS
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication
From GeneDx
Via Business Wire
Tickers WGS
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.